Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma

Jiro Kikuchi, Taeko Wada, Rumi Shimizu, Tohru Izumi, Miyuki Akutsu, Kanae Mitsunaga, Kaoru Noborio-Hatano, Masaharu Nobuyoshi, Keiya Ozawa, Yasuhiko Kano, Yusuke Furukawa

Blood (2010) 116 (3): 406–417.

https://doi.org/10.1182/blood-2009-07-235663

Published: 2010

Includes: Supplemental data

Journal Articles

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Shuichi Miyawaki, MD, PhD, Naoko Hatsumi, MD, Takahiro Yamauchi, MD, Kousuke Tsuboi, MD, Atsushi Fujieda, MD, Akihiro Takeshita, MD, Norio Komatsu, MD, Noriko Usui, MD, Yukihiro Arai, MD, Fumihiro Ishida, MD, PhD, Takeshi Morii, MD, Yasuhiko Kano, MD, Michinori Ogura, MD, PhD, Noriko Doki, MD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 1058.

https://doi.org/10.1182/blood.V114.22.1058.1058

Published: 2009

Journal Articles

Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.

Kaoru Hatano, Jiro Kikuchi, Masaaki Takatoku, Rumi Shimizu, Taeko Wada, Masuzu Ueda, Masaharu Nobuyoshi, Iekuni Oh, Kazuya Sato, Takahiro Suzuki, Katsutoshi Ozaki, Masaki Mori, Tadashi Nagai, Kazuo Muroi, Yasuhiko Kano, Yusuke Furukawa, Keiya Ozawa

Blood (2008) 112 (11): 1634.

https://doi.org/10.1182/blood.V112.11.1634.1634

Published: 2008

Journal Articles

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Hoang Anh Vu, MD, PhD, Phan Thi Xinh, M.D., Ph.D., Yasuhiko Kano, M.D., Ph.D., Takaomi Ishida, Ph.D, Toshiki Watanabe, M.D., Ph.D., Katsushi Tokunaga, Ph.D., Yuko Sato, M.D., Ph.D.

Blood (2007) 110 (11): 4666.

https://doi.org/10.1182/blood.V110.11.4666.4666

Published: 2007

Journal Articles

Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by Proteasome Inhibitor Bortezomib.

Krittaya Sutheesophon, MD, PhD, Yukiko Kobayashi, MD, Masa-aki Takatoku, MDPh.D, Keiya Ozawa, MDPh.D, Yasuhiko Kano, MDPh.D, Hideshi Ishii, MD, Yusuke Furukawa, MDPh.D

Blood (2005) 106 (11): 4454.

https://doi.org/10.1182/blood.V106.11.4454.4454

Published: 2005

Journal Articles

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

Akira Miyazato, Shuichi Ueno, Ken Ohmine, Masuzu Ueda, Koji Yoshida, Yoshihiro Yamashita, Takashi Kaneko, Masaki Mori, Keita Kirito, Masaki Toshima, Yuichi Nakamura, Kenji Saito, Yasuhiko Kano, Shinpei Furusawa, Keiya Ozawa, Hiroyuki Mano

Blood (2001) 98 (2): 422–427.

https://doi.org/10.1182/blood.V98.2.422

Published: 2001

Journal Articles

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Yasuhiko Kano, Miyuki Akutsu, Saburo Tsunoda, Hiroyuki Mano, Yuko Sato, Yoshio Honma, Yusuke Furukawa

Blood (2001) 97 (7): 1999–2007.

https://doi.org/10.1182/blood.V97.7.1999

Published: 2001

NARROW

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by Proteasome Inhibitor Bortezomib.

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Email alerts

ASH Publications

American Society of Hematology

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by Proteasome Inhibitor Bortezomib.

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only